BioCis Pharma Reports Positive Phase IIa Clinical Results in Atopic ... ( TURKU Finland July 3 /- BioCis Ph...)

BioCis Pharma Reports Positive Phase IIa Clinical Results in Atopic Dermatitis

Date:7/3/2009

TURKU, Finland, July 3 /PRNewswire/ -- BioCis Pharma Ltd., a privately held drug development company with its headquarters in Turku, Finland, announced positive results from its Phase IIa clinical trial of ProtoCure(TM) emulsion cream, the company's novel topical drug for dermatology. This double-blind, placebo-controlled study, conducted in Finland, included 13 patients with mild to moderate atopic dermatitis who applied the ProtoCure emulsion cream to the affected skin areas twice daily for up to four weeks. The objectives were to evaluate the tolerability, pharmacokinetics, and efficacy of the topical treatment.

Study results showed excellent safety profile, and no serious adverse events were reported during the study. No patient dropped out due to adverse side effects of the treatment. Pharmacokinetic analyses showed no systemic exposure to the active ingredient of the product. Efficacy was assessed by performing instrumental measurements of skin lesion redness (erythema) and skin barrier function by trans-epidermal water loss (TEWL) during the 28-day period. Physician assessments, such as Eczema Area and Severity Index (EASI) were also evaluated. ProtoCure emulsion cream was superior to placebo in decreasing skin redness and improving skin barrier function. Statistically significant improvement was observed as early as day 10 after begining treatment. There was also a significant improvement in EASI score over the whole treatment period for ProtoCure emulsion cream as a sign of positive treatment effect. The EASI score difference did not reach statistical significance when compared to placebo, mainly due to the small number of patients studied.

"We are very pleased with the promising results of this study," says Lasse Leino, CEO of BioCis Pharma. "Skin barrier dysfunction is now recognized as a hallmark feature of atopic dermatitis. Any drug showing capacity for restoring this disturbance has signi
'/>"/>

SOURCE BioCis Pharma Ltd
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine technology :

1. BioCis Pharma Starts a Phase I Clinical Trial With a New Cancer Drug
2. Pangu BioPharma, aTyr Pharmas Subsidiary in Hong Kong, Files Three Patent Applications
3. King Pharmaceuticals Showcases Data From Pain Pipeline of Medicines Designed to Deter Common Methods of Non-Therapeutic Use
4. Jazz Pharmaceuticals and UCB Announce Second Phase III Study of Sodium Oxybate in Patients With Fibromyalgia Meets Primary Endpoints
5. Conatus Pharmaceuticals Initiates a Second Phase 2 Clinical Trial for the Treatment of Hepatitis
6. Covance Announces Integrated Radiolabeled Clinical Pharmacology Studies
7. CeNeRx BioPharma Obtains Rights to Novel Drug Candidate for Prevention and Treatment of Neurodegeneration Disorders
8. VIA Pharmaceuticals Meets With FDA to Discuss Next Steps For VIA-2291 and Phase 3 Outcome Trial in Cardiovascular Disease
9. Oramed Pharmaceuticals to Present at the 8th National Life Science & Technology Week ILSI -BIOMED Conference, Israel 2009
10. Merz Pharmaceuticals Announce Three Studies of NT-201 - (Botulinum neurotoxin type A Free From Complexing Proteins)
11. DOR BioPharma Receives EMEA Agreement on the Design of its Confirmatory Phase 3 Clinical Trial of orBec(R) in GI GVHD

Post Your Comments:

(Date:2/9/2010)... Feb. 9 Volcano Corporation (Nasdaq: ... of precision intravascular therapy guidance tools designed to ... peripheral vascular disease, announced today that it has ... from Lumen Biomedical. Volcano became the exclusive global ... 2009 . This acquisition reinforces Volcano,s dedication to ...

(Date:2/9/2010)... Glycemion Strategies, Inc., an ... diabetic consumers and their professional healthcare providers, announced ... to benefit the 30,000 US Diabetes Educators and ... serve. ,, The Portrait Health™ ... provide real-time access to health information, especially in ...

(Date:2/9/2010)... SOUTHFIELD, Mich. , Feb. 9 /PRNewswire-FirstCall/ ... TEAM ), a worldwide provider of information technology ... that it has named Guido Roumans as director ... responsible for service delivery, relationship management and ongoing ... customers. ,, Roumans has nearly 20 years of ...

Breaking Medicine Technology:Volcano Corporation Completes Acquisition of Lumen Biomedical's Xtract(TM) Thrombus Aspiration Catheter 2 Volcano Corporation Completes Acquisition of Lumen Biomedical's Xtract(TM) Thrombus Aspiration Catheter 3 Volcano Corporation Completes Acquisition of Lumen Biomedical's Xtract(TM) Thrombus Aspiration Catheter 4 Volcano Corporation Completes Acquisition of Lumen Biomedical's Xtract(TM) Thrombus Aspiration Catheter 5 Portrait Health(TM) Emergency Medical Data Retrieval Program-Glycemion Strategies Announces Free Membership for Diabetes Educators 2 Portrait Health(TM) Emergency Medical Data Retrieval Program-Glycemion Strategies Announces Free Membership for Diabetes Educators 3 TechTeam Global Appoints Life Sciences Services Director 2 TechTeam Global Appoints Life Sciences Services Director 3 Echo Therapeutics to Present at Jessup 26 Lamont 2009 Growth Stock Conference 52099 1 Echo Therapeutics to Present at Jessup 26 Lamont 2009 Growth Stock Conference 52099 2 Regado Biosciences Expands Medical Advisory Board 13085 1 Regado Biosciences Expands Medical Advisory Board 13085 2 Regado Biosciences Expands Medical Advisory Board 13085 3 Regado Biosciences Expands Medical Advisory Board 13085 4 Elder Boom Will Be Felt Worldwide 52094 1 Elder Boom Will Be Felt Worldwide 52094 2

[0] Volcano Corporation Completes Acquisition of Lumen Biomedical's Xtract(TM) Thrombus Aspiration Catheter [0] Portrait Health(TM) Emergency Medical Data Retrieval Program-Glycemion Strategies Announces Free Membership for Diabetes Educators [0] TechTeam Global Appoints Life Sciences Services Director

... Oct. 11 KineMed Inc., a,pathway-based drug discovery ... the ability of an investigational agent,to regenerate nerve ... brain involved,with cognition and mood. The agent, part ... performance in a behavioral test in a,preclinical model. ...

... 11 deCODE genetics,(Nasdaq: DCGN ) today announced ... variations in the genome (called SNPs) that the company,has ... The SNPs are located on chromosome 9 and were ... journal Science in July, deCODE,scientists found that people who ...

Other Medicine Technology:KineMed Presents Preclinical Data for Investigational Agent Demonstrating Neurogenesis and Confirming Improvements in Behavioral Model 2 KineMed Presents Preclinical Data for Investigational Agent Demonstrating Neurogenesis and Confirming Improvements in Behavioral Model 3 deCODE Launches deCODE MI(TM) -- A Test for a Major Genetic Risk Factor for Early-onset Heart Attack 2 deCODE Launches deCODE MI(TM) -- A Test for a Major Genetic Risk Factor for Early-onset Heart Attack 3

KineMed Presents Preclinical Data for Investigational Agent Demonstrating Neurogenesis and Confirming Improvements in Behavioral Model deCODE Launches deCODE MI(TM) -- A Test for a Major Genetic Risk Factor for Early-onset Heart Attack

(Date:2/9/2010)... for bladder biopsies done in doctor,s office boosted ... (HealthDay News) -- After Medicare sweetened payments for ... York City practice performed many more in-office bladder ... roughly the same, a new study finds. , ... 50 percent after the U.S. Centers for Medicare ...

(Date:2/9/2010)... Feb. 9 The American Council ... and one of the largest fitness certification, education ... key findings from an exclusive study on the ... University of Wisconsin , La Crosse , ... that kettlebells provide a much higher-intensity workout than ...

(Date:2/9/2010)... Feb. 9 Vescent Labs Inc., ... announced today that a new infomercial featuring its revolutionary ... in February. Competitive Edge Media, based in San ... agency for the National TV campaign, and will represent ... Skyler Ditchfield , Vescent Labs Inc. CEO, said, "We,re ...

(Date:2/9/2010)... Movement to Fight Heart Disease in Eastern Washington , ... ... -- Jiffy Lube service centers in Spokane, Kennewick, Richland, Pasco, ... in year three of the Jiffy Lube Maintenance Partners for ... the American Heart Association’s Go Red For Women movement, the ...

(Date:2/9/2010)... City Fitness Philadelphia become the newest distributors for growing national ... ... February 9, 2010 -- Diet-to-Go, a national leader in the ... reach into the Philadelphia area by adding a pair of ... , ,The new locations help extend Diet-to-Go,s reach into the ...

Breaking Medicine News(10 mins):Health News:Medicare Cost-Saving Moves Can Backfire 2 Health News:Medicare Cost-Saving Moves Can Backfire 3 Health News:American Council on Exercise (ACE) Study Reveals Kettlebells Provide Powerful Workout in Short Amount of Time 2 Health News:American Council on Exercise (ACE) Study Reveals Kettlebells Provide Powerful Workout in Short Amount of Time 3 Health News:Company Invites Women to STOP PMS - Take the 10-Minute Challenge 2 Health News:Company Invites Women to STOP PMS - Take the 10-Minute Challenge 3 Health News: Eastern Washington Jiffy Lube Service Centers Embark on Year Three of Successful Maintenance Partners For Life Campaign 2 Health News: Eastern Washington Jiffy Lube Service Centers Embark on Year Three of Successful Maintenance Partners For Life Campaign 3 Health News: Eastern Washington Jiffy Lube Service Centers Embark on Year Three of Successful Maintenance Partners For Life Campaign 4 Health News:Diet-to-Go Welcomes 2 Key Philadelphia Fitness Centers as Partners-in-Health 2 Health News:Diet-to-Go Welcomes 2 Key Philadelphia Fitness Centers as Partners-in-Health 3

[0] Medicare Cost-Saving Moves Can Backfire [0] American Council on Exercise (ACE) Study Reveals Kettlebells Provide Powerful Workout in Short Amount of Time [0] Company Invites Women to STOP PMS - Take the 10-Minute Challenge [0] Eastern Washington Jiffy Lube Service Centers Embark on Year Three of Successful Maintenance Partners For Life Campaign [0] Diet-to-Go Welcomes 2 Key Philadelphia Fitness Centers as Partners-in-Health

... Robbins & Myers, Inc.,(NYSE: RBN ) announced ... Conference on November 11, 2008. The Company will be ... and Christopher,M. Hix, Vice President and Chief Financial Officer., ... CST, at,the Four Seasons Hotel in Chicago, Illinois. It ...

... Serious Lung Disease 4th Leading Cause of Death in ... is supporting,national COPD Awareness Month, to help raise awareness ... COPD Awareness Month, AllerAir will be making downloadable,tips available ... as well,as dedicating their November newsletter and blogs to ...

... TORONTO, Nov. 3 /PRNewswire-FirstCall/ - Bradmer Pharmaceuticals Inc.,a ... cancer therapies, announced today that Dr. Alan M.,Ezrin, ... will present a,corporate update at Rodman & Renshaw ... New York City from November 10th - 12th ...

... medicine company,PreMD Inc. (TSX: PMD; PREMF.pk) today announced it ... it is reviewing the eligibility of the,Company,s common shares ... is being reviewed under the TSX,s Remedial Review Process,and ... requirements for continued,listing. If the Company cannot demonstrate that ...

... and new stock ... repurchase program, BOSTON, ... radiology and medical image and information management solutions,today reported unaudited financial ... (Logo: http://www.newscom.com/cgi-bin/prnh/20060202/AMICASLOGO ), Q3 Financial Highlights ...

... more prone to act out than those without deployed kin ... military personnel deployed to Iraq and Afghanistan are more likely ... a new study shows. , Researchers studied 169 families with ... in a day-care center at a Marine base. , Of ...

Robbins & Myers to Present at Baird's 2008 Industrial Conference November 11, 2008 AllerAir Dedicates November to COPD Awareness Month Bradmer to present at Rodman & Renshaw Healthcare Conference Listing Review initiated by the Toronto Stock Exchange AMICAS Reports Financial Results for the Third Quarter Ended September 30, 2008 Kids With Parent in War Zone Face Behavior Risks

... Properly manufactured radiation protective eyewear can ... high quality frames and materials offer the ... Our lenses are made of Schott RS-520 ... standards. Most Pulse Glasses are offered with ...

... Stylish and comfortable eye protection ... approximately 90% of scatter radiation. Our high ... protection and comfort with minimized weight. Our ... leaded) optics that meet all industry standards. ...

... and comfortable eye protection Properly manufactured ... of scatter radiation. Our high quality frames ... comfort with minimized weight. Our lenses are ... that meet all industry standards. Most Pulse ...

... with the safety and comfort of the practitioner ... called SF-6) leaded glass, the industry standard for ... set for optical clarity, visible light transmission, power ... protecting your eyes, it also helps you look ...

Medicine Products:

Vet Economy Wrap Carbon Wrap Metal Standard

BioCis Pharma Reports Positive Phase IIa Clinical Results in Atopic ...( TURKU Finland July 3 /- BioCis Ph...),Health